SCHEMBL9050283

SCHEMBL9050283

C=C(C)c1csc(SC)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10158631 0.71
SCHEMBL23385727 0.71
SCHEMBL9414403 0.71 GSK3B (0.41)
SCHEMBL24079386 0.71
SCHEMBL19140478 0.70
SCHEMBL9047734 0.70
SCHEMBL226995 0.68 MAPT (0.39)
SCHEMBL24805359 0.67 MAPK14 (0.31)
SCHEMBL21963242 0.63 CA2 (0.71)
SCHEMBL56283 0.62 CA5A (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0555068-B1 Oxime derivatives as 5-lipoxygenase inhibitors ZENECA LTD (GB) 1996-04-10 EP disclosed
US-5482966-A LIPOXYGENASE ENZYME INHIBITORS AS ANTIINFLAMMATORY AGENTS ZENECA LIMITED (GB) 1996-01-09 US disclosed
EP-0610032-A1 Acetanilide derivatives ZENECA LIMITED (GB) 1994-08-10 EP disclosed
US-5332757-A Enzyme inhibitors ZENECA LIMITED (GB) 1994-07-26 US disclosed
EP-0555068-A1 Oxime derivatives as 5-lipoxygenase inhibitors ZENECA LIMITED (GB) 1993-08-11 EP disclosed